Rilutek (riluzole) tablets, the first drug approved for amyotrophic lateral sclerosis

Rhone-Poulenc Rorer is now marketing Rilutek (riluzole) tablets, the first drug approved for amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).

Rilutek inhibits the release of glutamate...and seems to improve survival by about 3 months.

If you need info about getting Rilutek, call 800/790-7832.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote